79|55|Public
50|$|Radiation burns {{should be}} covered by a clean, dry {{dressing}} {{as soon as possible}} to prevent infection. Wet dressings are not recommended. The presence of combined injury (exposure to radiation plus trauma or radiation burn) increases the likelihood of generalized sepsis. This requires administration of <b>systemic</b> <b>antimicrobial</b> therapy.|$|E
30|$|In {{spite of}} {{improved}} operating room, sterilization methods, barriers, surgical technique and routine <b>systemic</b> <b>antimicrobial</b> prophylaxis [2 – 5], SSIs are still {{considered to be}} the most common and costly healthcare-associated infection, accounting for 31 % of all HAIs among hospitalized patients [6, 7].|$|E
40|$|So far four {{randomized}} studies, {{three of}} them double-blind and placebo-controlled, have investigated the role of bismuth subsalicylate (BSS) {{in the treatment of}} travelers' diarrhea. When compared with placebo BSS significantly reduced the number of unformed stools and increased the proportion of patients free of symptoms {{at the end of the}} trial. In the two studies that compared BSS with loperamide, the latter agent brought significantly faster relief. Diarrhea accompanied by dysenteric symptoms was influenced most favorably by administration of <b>systemic</b> <b>antimicrobial</b> agents. In all four studies only minor adverse effects were noted with BSSor the other active agents. One may include loperamide and a <b>systemic</b> <b>antimicrobial</b> agent in one's travel kit; however, loperamide should not be used for dysentery, and the antimicrobial agent should not be used in uncomplicated cases. As an alternative, although it is less effective, BSS has the unique advantage of being safe enough to use for all patients with travelers' diarrhe...|$|E
40|$|No sponsorships or {{competing}} interests have been disclosed for this article. Objective. Acute otitis externa (AOE) {{is a common}} but pre-ventable ear condition. Clinical guidelines issued in 2006 recommended topical treatments for uncomplicated AOE, but <b>systemic</b> <b>antimicrobials</b> appear to be commonly pre-scribed. The objective of this analysis was to describe pre-and postguideline prescribing patterns by clinician specialty and antimicrobial type and assess trends over time. Study Design. Retrospective longitudinal analysis of a large insurance database. Setting. Outpatient departments in the United States. Methods. Initial outpatient visits in 2004 to 2010 for AOE (excluding visits with complicating conditions) were extracted from an insurance database. Prescription drug claims were linked and categorized by clinician specialty and antimicrobial type. Results. The analysis included 907, 261 initial outpatient visits. Use of <b>systemic</b> <b>antimicrobials</b> declined by 4. 9 % (95 % confidence interval [CI], 4. 1 %, 5. 7 %) from 36. 5 % of initial visits in 2004 to 32. 1 % in 2010. Use of systemic anti-microbials varied by specialty. <b>Systemic</b> <b>antimicrobials</b> were prescribed in 47. 1 % of 2010 emergency department (ED) visits (– 6. 9 % from 2004, 95 % CI – 12. 3, – 1. 5), 25. 9 % of oto-laryngologist visits (– 1. 6 %, 95 % CI – 5. 6, 2. 4), and 20. 4 % of pediatrician visits (– 6. 6 %, 95 % CI – 8. 8, – 4. 4). Penicillins were prescribed most frequently (42. 3 % of systemic prescriptions in 2010), followed by cephalosporins (19. 8 %), erythromycin/ macrolides (17. 4 %), and quinolones (11. 1 %). Opioids were pre-scribed in 26. 4 % of ED visits and 9 % of outpatient visits. Conclusions. Use of <b>systemic</b> <b>antimicrobials</b> declined over time, but one-third of 2010 visits resulted in <b>systemic</b> <b>antimicrobials,</b> despite exclusion of visits with complicating factors. Use of sys-temic antimicrobials varied by specialty. Further educational efforts and outreach to other specialties might be warranted...|$|R
40|$|ObjectiveAcute {{otitis externa}} (AOE) {{is a common}} but {{preventable}} ear condition. Clinical guidelines issued in 2006 recommended topical treatments for uncomplicated AOE, but <b>systemic</b> <b>antimicrobials</b> appear to be commonly prescribed. The objective of this analysis was to describe pre- and postguideline prescribing patterns by clinician specialty and antimicrobial type and assess trends over time. Study DesignRetrospective longitudinal analysis of a large insurance database. SettingOutpatient departments in the United States. MethodsInitial outpatient visits in 2004 to 2010 for AOE (excluding visits with complicating conditions) were extracted from an insurance database. Prescription drug claims were linked and categorized by clinician specialty and antimicrobial type. ResultsThe analysis included 907, 261 initial outpatient visits. Use of <b>systemic</b> <b>antimicrobials</b> declined by 4. 9...|$|R
40|$|An audit {{was done}} to {{determine}} the pattern of antimicrobial use in a small rural Canadian hospital. Over a three-month period, 85 (33. 7 %) of 252 hospitalized patients received <b>systemic</b> <b>antimicrobials.</b> The group comprised 19 children and 66 adults. Respiratory infections were most common in both children and adults, and ampicillin/amoxicillin was {{the most frequently used}} agent. Treatment was judged to be appropriate in all the children, but was inappropriate in 15 % of the adults. Adults who had superficial skin infections, and urinary tract infections with catheters in place, were most often inappropriately treated with <b>systemic</b> <b>antimicrobials.</b> The causes of inappropriate antimicrobial use and how to prevent it are discussed...|$|R
40|$|International audienceCentral-line {{access is}} an {{essential}} part of modern healthcare practice; however, catheter-related bloodstream infection is a major problem that causes substantial morbidity and mortality, and excess length of stay and cost. The risk of infection depends on the type of device, the site of insertion, the underlying conditions and the appropriate prevention measures taken during catheter insertion. Management of catheter-related bloodstream infection involves deciding on catheter removal, antimicrobial catheter lock solution and the type and duration of <b>systemic</b> <b>antimicrobial</b> therapy. <b>Systemic</b> <b>antimicrobial</b> use is essential but, although generally effective in controlling sepsis, it often fails to sterilize the line, increasing the incidence of complications or recurrence. The decision regarding whether the catheter should be removed or retained is therefore crucial. One of the major factors to be considered is the type of organism involved in the catheter-related infection. This review outlines the epidemiology, pathogenesis, diagnosis, microbiology and management of catheter-related infections, mainly focusing on the management of the intravascular device according to the pathogen...|$|E
40|$|A 59 -year-old woman {{suffering}} from rheumatoid arthritis was admitted with pleural empyema and pericarditis due to non-encapsulated H. influenzae, and developed signs of cardiac tamponade. Purulent pericarditis resolved after ultrasound guided percutaneous aspiration and <b>systemic</b> <b>antimicrobial</b> therapy. Serial echocardiographic examinations showed a slowly vanishing effusion. Long term follow-up revealed {{no evidence of}} pericardial constriction. This case illustrates that life-threatening purulent pericarditis in an immunocompromised patient may respond well to non-surgical treatment. (C) 1999 Elsevier Science B. V. All rights reserved...|$|E
30|$|Infectious {{crystalline}} keratopathy {{is commonly}} caused by Streptococcus viridans and other gram positive organisms. We present {{the first case}} of infectious crystalline keratopathy that developed into a corneal ulcer and grew Abiotrophia defectiva which responded well to topical and <b>systemic</b> <b>antimicrobial</b> therapy and did not require re-grafting. A 78 -year-old man underwent penetrating keratoplasty for pseudophakic bullous keratopathy. He presented 1.5 [*]years later with infectious crystalline keratopathy which progressed to a corneal ulcer. The patient received topical fortified vancomycin and moxifloxacin, as well as oral moxifloxacin.|$|E
40|$|In {{the past}} six decades more than 15 classes of <b>systemic</b> <b>antimicrobials</b> have been {{introduced}} into clinical practice but antibiotic armamentarium is being lost rapidly due to bacterial resistance. If the medical fraternity does not halt this process, {{it could lead to}} disastrous situation, akin to the pre-antibiotic era. We mus...|$|R
40|$|Figure 1 : Temporal {{variation}} in antibacterial usage by site (items/ 1000 patients) Topical antibacterials accounted for 197. 8 dispensed items/ 1000 registered patients per annum (ppa). Skin preparations {{were the most}} commonly dispensed items accounting for 48 % of topical usage across primary care in Wales in 2009. Antimicrobial stewardship programs {{tend to focus on}} the appropriate use of <b>systemic</b> <b>antimicrobials.</b> Little data exist regarding the extent of topical antibacterial use in Wales, the UK, or any other European countries, except for a few studies which have focuse...|$|R
40|$|The {{microbial}} infections {{involving the}} craniofacial skeleton, particularly maxilla and mandible, have direct {{relationship with the}} dental biofilm, with predominance of obligate anaerobes. In some patients, these infections may spread to bone marrow or facial soft tissues, producing severe and life-threatening septic conditions. In such cases, local treatment associated with <b>systemic</b> <b>antimicrobials</b> {{should be used in}} order to eradicate the sources of contamination. This paper discuss the possibility of spread of these infections and their clinical implications for dentistry, as well as their etiology and aspects related to microbial virulence and pathogenesis...|$|R
40|$|Hyperammoniemic {{encephalopathy}} {{has been}} reported after ureterosigmoidostomy. Its development is related to a problem of bacterial overgrowth and, most often, is favored {{by the presence of}} an underlying liver dysfunction. We report the case of a 43 -year-old woman with a ureterosigmoidostomy done 28 years earlier who developed hyperammoniemic coma induced by an acute rectocolitis {{and in the absence of}} any detectable liver dysfunction. Neither administration of Lactilol and neomycin nor rectal tube drainage were effective; <b>systemic</b> <b>antimicrobial</b> therapy effective against the urease-producing gram-negative bacilli was required and led to a decrease in serum ammonia levels and a dramatic clinical improvement. SCOPUS: ar. jinfo:eu-repo/semantics/publishe...|$|E
40|$|AbstractBackgroundProgressive macular hypomelanosis (PMH) is a cosmetically {{disturbing}} {{skin disorder}} that is poorly understood with indefinite treatment. The {{aim of the}} present study was to clinically outline PMH and study its pathogenesis. Based upon the literature suggesting improvement of PMH with antibiotic therapy to decrease Propionibacterium acnes (P. acnes) colonization, different treatment modalities were tried to reach the best treatment option. Patients and methodsThis study included 12 newly diagnosed PMH selected patients who attended Tanta University Hospital outpatient clinic of Dermatology and Venereology from June 2009 to March 2010. Patient's lesions were subjected to wood's lamp and potassium hydroxide (KOH) examination as well as biopsies used in histological, immunohistochemical, bacteriological and electron microscopic examination. A randomized clinical trial with different treatment modalities was applied. ResultsThe patient's mean age was 25 ± 10. 8 with significant female predominance (P= 0. 0001). Reduction of epidermal melanosomes and tyrosine activity together with difference in distribution of S 100 proteins in hypopigmented skin was demonstrated. Abnormal distribution of tonofilaments was noticed inside keratinocytes with increased apoptosis. P. acnes were detected in hair follicles of 83. 3 % hypopigmented lesions. Administration of local and <b>systemic</b> <b>antimicrobial</b> treatment with narrow band ultraviolet B (NBUVB) phototherapy for 3 months was the best treatment modalities. ConclusionThe etiology of PMH is multifactorial where genetic predisposition, the presence of P. acnes and hormonal imbalance play the main role. Administration of local and <b>systemic</b> <b>antimicrobial</b> treatment with NBUVB phototherapy for 3 months is an effective treatment regimen for PMH...|$|E
30|$|Gas-forming {{infections are}} a special matter of concern; {{clinical}} outcome will largely {{depend on a}} prompt diagnosis and treatment. Thus, imaging {{plays an important role}} to achieve the correct diagnosis and extension of the disease. Generally, successful treatment requires aggressive management of the infection with <b>systemic</b> <b>antimicrobial</b> therapy and control of septic shock. Most of the time, these patients are candidates for surgical interventions such as debridement or percutaneous drainage in emphysematous pancreatitis and surgical/percutaneous drainage or even nephrectomy in refractory emphysematous pyelonephritis. Patients with necrotising fasciitis are early submitted to surgical debridements of the affected areas in order to remove all non-viable tissue and help relieve the cause of systemic toxicity [1].|$|E
40|$|Atopic eczema/dermatitis {{from the}} aspects of {{immunologic}} background, genetics, skin barrier dysfunction, IgE receptors, and triggers of AD (including allergens, microorganisms, and autoantigens) is described. Also reviewed are diagnostic procedures, treatment modalities with topical treatment (emollients, topical corticosteroids, topical calcineurin inhibitors, wet wrap therapy, and topical <b>antimicrobial</b> therapy), <b>systemic</b> management (<b>antimicrobials,</b> <b>systemic</b> corticosteroids, cyclosporine A, azathioprine, antihistamines), and phototherapy. Primary and secondary prevention are discussed {{and the role of}} the different cell receptors and their up-and down-regulation in this setting are emphasized...|$|R
40|$|No sponsorships or {{competing}} interests have been disclosed for this article. Objective. Acute otitis externa (AOE) {{is a common}} but pre-ventable ear condition. Clinical guidelines issued in 2006 recommended topical treatments for uncomplicated AOE, but <b>systemic</b> <b>antimicrobials</b> appear to be commonly pre-scribed. The objective of this analysis was to describe pre-and postguideline prescribing patterns by clinician specialty and antimicrobial type and assess trends over time. Study Design. Retrospective longitudinal analysis of a large insurance database. Setting. Outpatient departments in the United States. Methods. Initial outpatient visits in 2004 to 2010 for AOE (excluding visits with complicating conditions) were extracted from an insurance database. Prescription drug claims wer...|$|R
40|$|Antimicrobials are {{the most}} common {{medicines}} prescribed to children, but very little is known about patterns of hospital paediatric antimicrobial prescribing. This study aimed at describing paediatric antimicrobial prescribing in European hospitals to identify targets for quality improvement. The European Surveillance of Antibiotic Consumption (ESAC) project (www. esac. ua. ac. be) collected data during 2 calendar weeks between May and June 2008 in 32 hospitals of 21 European countries with paediatric departments, using a standardized method. The ESAC point prevalence survey included all inpatient beds and identified all patients who were receiving <b>systemic</b> <b>antimicrobials</b> {{on the day of the}} survey or had received antimicrobial surgical prophylaxis on the previous day. Of 1799 children, 583 (32...|$|R
40|$|Abstract Eczema is {{a chronic}} {{relapsing}} atopic dermatitis (AD) associated with pruritus, sleep disturbance and poor {{quality of life}} of the patient. Treatment of eczema includes use of emollient, topical and <b>systemic</b> <b>antimicrobial</b> agents, corticosteroid or immunomodulating agents. Many patients also seek alternative treatments such as dietary avoidance, supplementation or both. This article reviews the basic pathophysiology of eczema and clinical trials involving Chinese medicine in the treatment of eczema. Research reports on Chinese herbal medicine for eczema were retrieved from PubMed and the Cochrane Database for Systematic Reviews for this review. Only a few RCTs demonstrated the efficacy (or lack of efficacy) of Chinese medicinal herbs in treating atopic eczema. Further larger scale trials are warranted. </p...|$|E
30|$|In most cases, {{antibiotics}} {{effective against}} multidrug-resistant (MDR) strains of Gram-negative bacteria (extended-spectrum beta-lactamase [ESBL]-producing K. pneumonia, Acinetobacter sp. and P. aeruginosa) were administered only after isolation of these pathogens from intraoperative cultures of infected tissues and/or removed {{components of the}} implant. In addition, gentamicin which is released from bone cement has low activity against this type of pathogens. Therefore, ineffective initial therapy with local antibiotics present in cement spacers and <b>systemic</b> <b>antimicrobial</b> regimens might have led to an unsuccessful outcome of PJI. Of nine patients with monomicrobial PJI, caused by Gram-negative MDR strains, only one patient had sustained remission. Of 18 patients with polymicrobial infection, caused by microbial associations with MDR strains, {{the first step of}} the two-stage procedure was also successful in one patient.|$|E
40|$|Everything about {{ventilator}} associated pneumonia is conten-tious. What is {{the microbial}} pathogenesis? How {{can it be}} prevented? How should it be treated? One strongly advocated preventive strategy consists of intensive topical and <b>systemic</b> <b>antimicrobial</b> prophylaxis. An opposing but equally strongly advocated approach {{is the use of}} conven-tional but firmly applied infection control measures together with limitation of antibiotic use. For treatment, questions abound. One drug or two? Which drug? For how long? There are two main reasons which underlie our failure to move toward consensus on many of these questions. Firstly, the magnitude and nature of the problem varies widely between intensive care units. The incidence of pneumonia in mechanically ventilated patients ranges from as little as 5 % in some units to more than 50 % in others. 1 –...|$|E
30|$|This study {{demonstrated}} a {{slow but steady}} increase in fidaxomicin utilization over time; most of which was combined with other <b>systemic</b> antibiotics. <b>Antimicrobial</b> stewardship teams should provide guidance on appropriate use of fidaxomicin to optimize therapy and assess the need to continue other antibiotics during CDI treatment.|$|R
40|$|Many <b>systemic</b> <b>antimicrobials</b> {{have been}} implicated to cause ocular adverse effects. This is {{especially}} relevant in multidrug therapy {{where more than}} one drug can cause a similar ocular adverse effect. We describe a case of progressive loss of vision associated with linezolid therapy. A 45 -year-old male patient who was on treatment with multiple second-line anti-tuberculous drugs including linezolid and ethambutol for extensively drug-resistant tuberculosis (XDR-TB) presented to us with painless progressive loss of vision in both eyes. Color vision was defective and fundus examination revealed optic disc edema in both eyes. Ethambutol-induced toxic optic neuropathy was suspected and tablet ethambutol was withdrawn. Deterioration of vision occurred despite withdrawal of ethambutol. Discontinuation of linezolid resulted in marked improvement of vision. Our report emphasizes the need for monitoring of visual function in patients on long-term linezolid treatment...|$|R
30|$|Aerosolized {{antibiotic}} therapy also provides {{the potential for}} a reduction in the overall use of systemic antibiotics [24, 41], with clear benefits for antibiotic stewardship and management of emergent resistance. Increased resistance due to frequent or excessive use of <b>systemic</b> <b>antimicrobials</b> has been documented for several drug classes. For example, between 2007 and 2011 the increased use of amoxicillin/clavulanic acid, ceftazidime and cefepime, carbapenems, and fluoroquinolones has correlated with an increase in the incidence of resistance in isolates of K. pneumoniae, P. aeruginosa and AmpC-producing Enterobacteriaceae, among others [42, 43]; decreasing the general use of antibiotics is therefore a key aim of antimicrobial stewardship programs. Importantly, this goal may be aided by the wider use of aerosolized therapies, and results from a Phase II study demonstrated that inhaled antibiotics could significantly reduce the use of IV antibiotics [44].|$|R
40|$|The {{purpose of}} this {{manuscript}} is to report {{the case of an}} 81 -year-old patient who presented with bilateral keratitis after phacoemulsification surgery. Cultures came back positive for Mycobacterium chelonae. Despite aggressive topical and <b>systemic</b> <b>antimicrobial</b> treatment, the patient developed a corneal perforation in both eyes, treated with corneal glue in the right eye and corneoscleral patch in the left eye. After two years of follow-up, patient was free of infection in the right eye with visual acuity of 20 / 200 and the left eye progressed to phthisis bulbi. We present an unusual case of bilateral Mycobacterium chelonae keratitis associated with phacoemulsification cataract surgery. This case represents the importance of making clinicians aware of this devastating infection and highlights the need for better management to improve outcomes...|$|E
30|$|Infectious {{crystalline}} keratopathy (ICK) {{was first}} described in 1983 {{and is a}} rare complication following corneal transplantation and chronic inflammation [1]. It {{is characterized by the}} formation of branching and crystalline-appearing opacities deep in the corneal stroma that are formed from localized invasion of microorganisms without adjacent inflammation. Streptococcus viridans is the most common causative organism, but other common pathogens include Staphylococcus epidermidus, Corynebacterium, Pseudomonas aeruginosa, and fungi [2]. We present a case of a man with infectious crystalline keratopathy that developed into a corneal ulcer and grew Abiotrophia defectiva, or nutritionally deficient streptococcus (NDS), which responded well to topical and <b>systemic</b> <b>antimicrobial</b> therapy and did not require re-grafting. An IRB waiver was granted, and consent was obtained from the patient. All research was performed in accordance with the Declaration of Helsinki and all local, regional, and national laws.|$|E
40|$|A {{prominent}} response {{during the}} Drosophila host defence is the induction of proteolytic cascades, {{some of which}} lead to localized melanization of pathogen surfaces, while others activate {{one of the major}} players in the <b>systemic</b> <b>antimicrobial</b> response, the Toll pathway. Despite the fact that gain-of-function mutations in the Toll receptor gene result in melanization, a clear link between Toll activation and the melanization reaction has not been firmly established. Here, we present evidence for the coordination of hemolymph-borne melanization with activation of the Toll pathway in the Drosophila host defence. The melanization reaction requires Toll pathway activation and depends on the removal of the Drosophila serine protease inhibitor Serpin 27 A. Flies deficient for this serpin exhibit spontaneous melanization in larvae and adults. Microbial challenge induces its removal from the hemolymph through Toll-dependent transcription of an acute phase immune reaction component...|$|E
40|$|Patients {{with certain}} {{cardiovascular}} abnormalities are recognised to beat risk - and some {{at high risk}} - of developing infective endocarditis following episodes of bacteraemia. Whenever a clinically important bacteraemia is anticipated in such susceptible patients, chemoprophylaxis (use of <b>systemic</b> <b>antimicrobials)</b> is advocated. However, the effectiveness of such measures remains unclear. Patients undergoing dentisty/oral surgery (especially extractions) experience bacteraemias (mainly viridans streptococci) lasting minutes. For susceptible patients undergoing the latter procedures, {{it is appropriate to}} sensibly educate them about the risks, ensure good dental hygiene, consider prior topical antisepsis, and be vigilant to the possible failure of chemoprophylaxis. Currently advocated chemoprophylactic guidelines are confusing and ambiguous. For patients susceptible to infective endocarditis - including those at high risk - undergoing potentially bacteraemic dental/oral surgical procedures, the recommendations in this account have been simplified. In individuals with a history of penicillin hypersensitivity or recent exposure, instead of erythromycin, the use of clindamycin (orally) or vancomycin (parenterally) is stressed. published_or_final_versio...|$|R
40|$|INTRODUCTION: The remit of this {{working group}} was {{to update the}} {{existing}} knowledge base in non-surgical periodontal therapy. The published systematic reviews from the fourth EAP Workshop formed {{the starting point for}} this update and in addition specific innovations not covered in previous workshops were included. MATERIAL AND METHODS: The literature was systematically searched and critically reviewed. Five manuscripts were produced in five specific topics identified as areas where innovative approaches have been developed in non-surgical periodontal therapy and which were deemed to be strategically important for patient care and clinical practice. RESULTS: The results and conclusions of the review process are presented in the following papers, together with the group consensus statements, clinical implications and directions for future research: A systematic review of the effects of full mouth debridement with and without antiseptics in patients with chronic periodontitis. Advances in Power Driven Instrumentation. Laser application in non-surgical periodontal therapy - a systematic review. Antimicrobial therapy in periodontitis: the use of <b>systemic</b> <b>antimicrobials</b> against the subgingival biofilm. The cost-effectiveness of supportive periodontal-care for patients with chronic periodontitis. status: publishe...|$|R
40|$|Exit site {{infection}} (ESI) is {{an important}} clinical problem in peritoneal dialysis (PD) patients and is a significant cause of peritonitis and catheter loss. While most ESIs are caused by skin commensals, rising incidence of atypical and resilient organisms such as mycobacteria, Pseudomonas and Burkholderia species has been observed. The diagnosis and management of these emerging pathogen remain difficult and poorly defined. This chapter highlights the evaluation and management of ESI in PD patients. The clinical features, microbiology, and ultrasonographic findings are discussed. The general and specific management of ESI due to different organisms will also be elaborated. ESI is usually a clinical diagnosis, {{but the use of}} bedside ultrasound can help assess for any collection around the cuff and tunnel tract involvement. Topical prophylaxis remains an effective way to prevent ESI. While the majority ESIs are related to skin flora and can be managed successfully by topical or <b>systemic</b> <b>antimicrobials,</b> clinicians should be alert to the emergence of resistant and atypical microorganisms. Surgical treatment should be reserved for ESI refractory to medical treatment or those with associated peritonitis...|$|R
40|$|Approximately {{three-quarters of}} all women will {{experience}} an episode of vulvovaginal candidosis {{at least once in}} their life and 5 - 10 % of them will have more than one attack. Women suffering from three to four attacks within 12 months will be diagnosed with recurrent vulvovaginal candidosis (RVVC). This review covers the large number of proposed aetiological factors for RVVC. The diagnosis of the condition made by conventional means by health providers is often false and is also often misdiagnosed by the affected woman herself. The review covers various methods of diagnosing RVVC and the current knowledge on potential pathogenetic mechanisms proposed for genital candida infections. Treatment of RVVC, including local and <b>systemic</b> <b>antimicrobial</b> therapy and behaviour modification to decrease the risk of recurrences, are discussed. Recent knowledge on drug resistance in candida is also included...|$|E
40|$|We {{evaluated}} short-term <b>systemic</b> <b>antimicrobial</b> prophylaxis for catheter-associated bacteriuria {{in women}} undergoing elective gynecological operations in a prospective, controlled, double-masked study. Nine of 100 placebo-treated patients acquired bacteriuria during catheterization compared with 3 of 96 of the drug-treated group. However, {{at the time}} of hospital discharge, clean-voided urine specimens were positive as frequently in the drug-treated group (8 of 82 patients cultured) as in the placebo group (8 of 75 patients cultured). No difference in febrile morbidity due to bacteriuria was noted between the prophylaxis and placebo groups. The incidence of catheter-associated bacteriuria may be reduced by antimicrobial prophylaxis. However, because the protective effect is transient and is associated with the selection of resistant organisms, prophylaxis is not indicated for patients at low risk for acquired bacteriuria and in whom the sequelae of catheter-associated infections are infrequent...|$|E
40|$|The {{development}} and spread of antimicrobial resistance is of considerable and growing concern. To {{better understand the}} relationship between the use of antimicrobial drugs and emerging antimicrobial resistance, surveillance of the antimicrobial use should take place. The main aim {{of this study was to}} obtain baseline data on <b>systemic</b> <b>antimicrobial</b> veterinary medicinal product (VMP) usage in dogs and cats in the Netherlands, by starting to quantify and asses the usage of <b>systemic</b> <b>antimicrobial</b> VMP’s in dog and cats in the Netherlands during 2009 - 2011, using the daily dosage per animal year (DDD/j) as the unit of measurement. All Dutch small animal veterinary practices were invited. Data recorded in practice management systems (PMS’s) of 68 veterinary practices were used to calculate the DDD/j. In 2009 the average dog and cat in the Netherlands received 3, 42 DDD/j (n= 59 practices), decreasing to 3, 40 DDD/j in 2010 (n= 65 practices) and 3, 23 DDD/j in 2011 (n= 67 practices). The most received classes of antimicrobial VMP’s in dogs and cats in the Netherlands are the combination of penicillins, inclusive beta-lactamase inhibitors (amoxicillin/clavulanic acid) : 38, 29 %, 36, 32 %, 38, 24 %, respectively 2009 (n= 59), 2010 (n= 65), 2011 (n= 67), followed by the penicillins with extended spectrum (amoxicillin, ampicillin) : 13, 19 %, 13, 01 %, 11, 73 %, respectively 2009 (n= 59), 2010 (n= 65), 2011 (n= 67). The third and fourth most received classes of antimicrobial VMP’s in dogs and cats in the Netherlands are the cephalosporins 3 rd generation (cefovecin) : 11, 95 %, 11, 14 %, 10, 23 %, respectively 2009 (n= 59), 2010 (n= 65), 2011 (n= 67) and cephalosporins 1 st generation (cefalexin, cefadroxil) : 10, 63 %, 11, 43 %, 11, 25 %, respectively 2009 (n= 59), 2010 (n= 65), 2011 (n= 67). Monitoring of the antimicrobial VMP use is important and general surveillance programs for companion animals should be used to monitor the extent and pattern of antimicrobial VMP usage and trends of antimicrobial resistance in companion animals in near future...|$|E
40|$|Objective. Biofilms {{have been}} shown {{to play a major role}} in the {{pathogenesis}} of otolaryngologic infections. However, very limited studies have been undertaken to demonstrate the presence of biofilms in tissues from patients with chronic otitis media (COM) with or without cholesteatoma. Our objective is to study the presence of biofilms in humans with chronic suppurative and nonsuppurative otitis media and cholesteatoma. Study Design. In all, 102 tissue specimens (middle ear, mastoid tissue, and ossicle samples) were collected during surgery from 34 patients. Methods. The samples were processed for the investigation of biofilms by scanning electron microscopy (SEM). Results. Our research supports the hypothesis in which biofilms are involved in chronic suppurative otitis media, cholesteatoma, and, to a lesser degree, chronic nonsuppurative otitis media. There were higher rates in hypertrophic and granulated tissue samples than in normal mucosa. In addition, the presence of biofilms was significantly higher in the middle ear mucosa compared with the mastoid and ossicle samples. Conclusion. In the clinic, the careful use of topical or <b>systemic</b> <b>antimicrobials</b> is essential, and, during surgery, hypertrophic tissue must be carefully removed from normal tissue...|$|R
40|$|Introduction: Brain empyema in {{children}} is a rare intracranial infection that may result from meningitis, sinusitis, or mechanisms such as head trauma, neurological surgery or hematogenous spread from a remote site. Objective: To describe a case of brain empyema caused by Escherichia coli in an infant. Methodology: A case report is presented with isolation of Escherichia coli arising after the overlap period of meningitis (1 - 3 months). A literature review of the risk factors, etiology and treatment of brain empyema {{in children}} is conducted. Results: The case report is about a 5 month-old male infant with no history of immunodeficiency, plagiocephalic, and with a 3 week-long history of otitis prior to admission. The patient had fever, seizures and rostro-caudal deterioration, cerebrospinal fluid pleocytosis and hypoglycorrhachia. The tomographic images revealed brain empyema. It was posible to isolate Escherichia coli from culture and surgical drainage was required plus systemic antibiotic therapy for 4 weeks. Conclusions: Brain empyema caused by Escherichia coli in infants after the overlap period are very rare. Treatment consists in prompt surgical evacuation, eradication of the primary infection and proper administration of <b>systemic</b> <b>antimicrobials...</b>|$|R
40|$|Clostridium difficile–associated {{diarrhea}} and colitis {{have emerged as}} major complications associated with use of <b>systemic</b> <b>antimicrobials.</b> In this study, the medical records for 18 subjects who received donor stool by nasogastric tube for recurrent C. difficile infection during a 9 -year period at a single institution were retro-spectively reviewed. During the period between the initial diagnosis of C. difficile colitis and the stool treat-ments, the 18 subjects received a total of 64 courses of antimicrobials (range, 2 – 7 courses; median, 3 courses). During the 90 days after receipt of treatment with stool, 2 patients died of unrelated illnesses. One of the 16 survivors experienced a single recurrence of C. difficile colitis during 90 -day follow-up. No adverse effects associated with stool treatment were observed. Patients with recurrent C. difficile colitis may benefit from the introduction of stool from healthy donors via a nasogastric tube. Pseudomembranous colitis was first described in 1893 [1]. By the 1960 s, most cases of pseudomembranous colitis were associated with previous use of antimicro-bial agents. The role of Clostridium difficile {{as a cause of}} diarrhea was described in 1978 [2]. Today, C. difficile is a leading cause of antibiotic-associated diarrhea an...|$|R
